IL1B and gout: Arnold et al. conducted a systematic literature review on the safety and efficacy of IL-1-targeted biologics in treating various immune-mediated disorders, including gout, however, their results were limited to RCTs, [11] whereas this review specifically focuses on available evidence on gout.